Table 1

Summary of patient demographics, CM laterality and location, BCVA, symptoms, systemic and ocular comorbidities associated to CM in the study cohort

FeatureN (%)Systemic comorbiditiesn=13 (%)
Sex Hypertension5 (39)
 Female8 (62) Diabetes mellitus3 (23)
 Male5 (38) Hypothyroidism1 (8)
Age (years) Peripheral vascular disease1 (8)
 Mean66 Heart disease1 (8)
 Median67 Hyperlipidaemia1 (8)
 Range27–92 Benign prostatic hypertrophy1 (8)
Ethnicity Vertigo1 (8)
 Caucasian4 (31) Breast cancer1 (8)
 African2 (15)Ocular co-morbiditiesn=16 (%)
 Afro-caribbean1 (8)
 N/A7 (46) Glaucoma4 (25)
Laterality Age-related macular degeneration3 (19)
 RE2 (15) Non-proliferative diabetic retinopathy2 (13)
 LE8 (62) Retinal detachment1 (6)
 BE3 (23) Central retinal vein occlusion1 (6)
Location Branch retinal vein occlusion1 (6)
 Macular14 (88)
 Extramacular2 (12)
Location relative to fovea
 Temporal7 (50)
 Supero-temporal4 (29)
 Supero-nasal1 (7)
 Nasal and temporal1 (7)
 Superior and inferior1 (7)
BCVA (Snellen, logMAR)
 Mean6/7.5 (0.10 logMAR)
 Range6/6-6/60 (0–1 logMAR)
Symptoms
 Yes2 (13)
 No14 (87)
  • BCVA, best corrected visual acuity; BE, both eyes; CM, choroidal macrovessel; LE, left eye; logMAR, logarithm of the minimum angle of resolution; N/A, not available; RE, right eye.